116 related articles for article (PubMed ID: 2993495)
1. Serum antibodies to the major HSV-2-specified DNA-binding protein in patients with an acute HSV infection or cervical neoplasia.
Lehtinen M; Lehtinen T; Koivisto V; Paavonen J; Leinikki P
J Med Virol; 1985 Jul; 16(3):245-56. PubMed ID: 2993495
[TBL] [Abstract][Full Text] [Related]
2. Lack of serum antibodies to the major HSV-2 specified DNA-binding protein before diagnosis of cervical neoplasia.
Lehtinen M; Hakama M; Knekt P; Heinonen PK; Lehtinen T; Paavonen J; Teppo L; Leinikki P
J Med Virol; 1989 Feb; 27(2):131-6. PubMed ID: 2537883
[TBL] [Abstract][Full Text] [Related]
3. HSV-IgA serum antibodies in cervical intraepithelial neoplasia and invasive cancer patients, and in their spouses: a case control study.
Gupta MM; Jain R; Parashari A; Singh V; Satyanarayana L
APMIS; 1992 Jul; 100(7):598-604. PubMed ID: 1322678
[TBL] [Abstract][Full Text] [Related]
4. Purification of herpes simplex virus-specified major DNA-binding proteins and detection of antibodies to them in human and rabbit sera.
Lehtinen M; Lehtinen T; Koivisto V; Paavonen J; Leinikki P
Acta Virol; 1984 Nov; 28(6):449-56. PubMed ID: 6152122
[TBL] [Abstract][Full Text] [Related]
5. Relation between cervical carcinoma and HSV-2 infection: herpetic agent in tumoral cells identified by immunofluorescence.
Borri P; Buzzoni P; Golin L; Locatelli F; Pieroni G; Savino L
Eur J Gynaecol Oncol; 1980 Dec; 1(3):146-9. PubMed ID: 6281015
[No Abstract] [Full Text] [Related]
6. Immunological reactivity of human sera with individual herpes simplex proteins: a comparative study of sera from patients with preinvasive or invasive cervical cancer and from controls.
Teglbjaerg CS; Feldborg R; Norrild B
J Med Virol; 1986 Feb; 18(2):169-80. PubMed ID: 3005489
[TBL] [Abstract][Full Text] [Related]
7. Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma.
Lehtinen M; Leminen A; Kuoppala T; Tiikkainen M; Lehtinen T; Lehtovirta P; Punnonen R; Vesterinen E; Paavonen J
J Med Virol; 1992 Jul; 37(3):180-6. PubMed ID: 1331306
[TBL] [Abstract][Full Text] [Related]
8. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
Thomas DB; Rawls WE
Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
[TBL] [Abstract][Full Text] [Related]
9. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus. An expanding relationship to human cancer.
Smith JW
J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
Vestergaard BF
Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
[TBL] [Abstract][Full Text] [Related]
12. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
13. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
[No Abstract] [Full Text] [Related]
14. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
Suárez M; Del Campo G; Ojeda JM
Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
[No Abstract] [Full Text] [Related]
15. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
Gilman SC; Docherty JJ; Clarke A; Rawls WE
Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
[TBL] [Abstract][Full Text] [Related]
16. [Genital herpes and cervical cancer].
Posevaia TA; Barinskiĭ IF
Vopr Virusol; 1983; 28(5):518-30. PubMed ID: 6197814
[No Abstract] [Full Text] [Related]
17. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment.
Vonka V; Kanka J; Hirsch I; Závadová H; Krcmár M; Suchánková A; Rezácová D; Broucek J; Press M; Domorázková E
Int J Cancer; 1984 Jan; 33(1):61-6. PubMed ID: 6319297
[TBL] [Abstract][Full Text] [Related]
18. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
[TBL] [Abstract][Full Text] [Related]
19. A filamentous distribution for the herpes simplex virus type 2-encoded major DNA-binding protein.
Rose DS; Shriver K; Latchman DS; LaThangue NB
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1315-25. PubMed ID: 3014046
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia trachomatis and cervical neoplasia.
Schachter J; Hill EC; King EB; Heilbron DC; Ray RM; Margolis AJ; Greenwood SA
JAMA; 1982 Nov; 248(17):2134-8. PubMed ID: 6288978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
